Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines

The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed. The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry Vol. 18; no. 16; pp. 4700 - 4704
Main Authors: Perry, Benjamin, Alexander, Rikki, Bennett, Gavin, Buckley, George, Ceska, Tom, Crabbe, Tom, Dale, Verity, Gowers, Lewis, Horsley, Helen, James, Lynwen, Jenkins, Kerry, Crépy, Karen, Kulisa, Claire, Lightfoot, Helen, Lock, Chris, Mack, Stephen, Morgan, Trevor, Nicolas, Anne-Lise, Pitt, Will, Sabin, Verity, Wright, Sara
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 15-08-2008
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed. The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
0968-0896
1464-3405
1464-3391
DOI:10.1016/j.bmcl.2008.06.104